TESARO Announces Inclusion of VARUBI in NCCN Antiemesis Guidelines
September 24, 2015 at 08:28 AM EDT
TESARO, Inc. (NASDAQ: TSRO) today announced the decision of the National Comprehensive Cancer Network (NCCN) to include VARUBI™ ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.